Cargando…
Heartburn in Consumer-Directed Health Care and the Cost Outcomes of Therapeutic Maximum Allowable Cost
In 2005, the Agency for Healthcare Research and Quality (AHRQ) launched its comparative effectiveness initiative with the goal of providing information to consumers and health care providers to assist in making more informed choices among treatment alternatives.1 AHRQ evaluated the treatments for he...
Autor principal: | Curtiss, Frederic R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437402/ https://www.ncbi.nlm.nih.gov/pubmed/16792448 http://dx.doi.org/10.18553/jmcp.2006.12.5.402 |
Ejemplares similares
-
TMAC Savings of 90% for Heartburn Drugs in the United States
por: Curtiss, Frederic R.
Publicado: (2006) -
OTC Omeprazole for Your Heartburn - Enormous Value-for-Money Opportunity
por: Curtiss, Frederic R.
Publicado: (2004) -
Prescription-Equivalent Over-the-Counter Drugs for Allergy, Heartburn, and Cholesterol Reduction
por: Curtiss, Frederic R.
Publicado: (2005) -
David and Goliath - Employer Takes on Health Care Cost Management
por: Curtiss, Frederic R.
Publicado: (2004) -
Reducing the Risk of Fractures - The Options Narrow for Cost-Effective Therapeutic Alternatives
por: Curtiss, Frederic R.
Publicado: (2004)